PE-22-28 is a synthetic peptide derived from spadin, known for its potential antidepressant and neuroprotective properties. It targets the TREK-1 potassium channel, which is involved in regulating mood and neuronal activity. PE-22-28 has shown promise in preclinical studies for rapidly reducing symptoms of depression without the side effects commonly seen in traditional antidepressants.
Reviews
There are no reviews yet.